Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suhas Vasaikar

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2021
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancerNoor Mazin Abdulkareem, Raksha Bhat, Lanfang Qin, et al.
British Journal of Pharmacology|February 18, 2025
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancerNoor Mazin Abdulkareem, Raksha Bhat, Micah Castillo, et al.
Cancers|October 27, 2019
The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing <i>GLS2</i> ExpressionEsmeralda Ramirez-Peña, James Arnold, Vinita Shivakumar, et al.
BMC Cancer|February 8, 2018
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?Suhas Vasaikar, Giorgos Tsipras, Natalia Landázuri, et al.
Oncotarget|July 1, 2016
Human cytomegalovirus may promote tumour progression by upregulating arginase-2Helena Costa, Xinling Xu, Gitta Overbeek, et al.
Journal of Clinical Medicine|October 27, 2019
A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast CancerHariprasad Thangavel, Carmine De Angelis, Suhas Vasaikar, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Cancer Research|June 20, 2019
Chromosome 12p Amplification in Triple-Negative/<i>BRCA1-</i>Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin SensitivityJorge Gómez-Miragaya, Ander Díaz-Navarro, Raul Tonda, et al.
British Journal of Cancer|April 2, 2021
CD8<sup>+</sup> T cells inhibit metastasis and CXCL4 regulates its functionRobiya Joseph, Rama Soundararajan, Suhas Vasaikar, et al.
Iscience|January 9, 2023
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Lacey E Dobrolecki, Lillian Thistlethwaite, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2021
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancerNoor Mazin Abdulkareem, Raksha Bhat, Lanfang Qin, et al.
British Journal of Pharmacology|February 18, 2025
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancerNoor Mazin Abdulkareem, Raksha Bhat, Micah Castillo, et al.
Cancers|October 27, 2019
The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing <i>GLS2</i> ExpressionEsmeralda Ramirez-Peña, James Arnold, Vinita Shivakumar, et al.
BMC Cancer|February 8, 2018
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?Suhas Vasaikar, Giorgos Tsipras, Natalia Landázuri, et al.
Oncotarget|July 1, 2016
Human cytomegalovirus may promote tumour progression by upregulating arginase-2Helena Costa, Xinling Xu, Gitta Overbeek, et al.
Journal of Clinical Medicine|October 27, 2019
A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast CancerHariprasad Thangavel, Carmine De Angelis, Suhas Vasaikar, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Cancer Research|June 20, 2019
Chromosome 12p Amplification in Triple-Negative/<i>BRCA1-</i>Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin SensitivityJorge Gómez-Miragaya, Ander Díaz-Navarro, Raul Tonda, et al.
British Journal of Cancer|April 2, 2021
CD8<sup>+</sup> T cells inhibit metastasis and CXCL4 regulates its functionRobiya Joseph, Rama Soundararajan, Suhas Vasaikar, et al.
Iscience|January 9, 2023
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Lacey E Dobrolecki, Lillian Thistlethwaite, et al.
Pageof 3